1 Min Read
March 20 (Reuters) - Jazz Pharmaceuticals Plc
* Jazz pharmaceuticals announces positive results from the phase 3 tones 3 and tones 4 studies of jzp-110 in patients with obstructive sleep apnea Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.